drug
tiopronin
Marketedupdated 4mo agoby Mission Pharmacal Co
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying tiopronin
Patent cliff
source: FDA Orange Bookfirst barrier falls
Nov 14, 2038
~12.2 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Nov 14, 2038method-of-use (U-3441)US 11458104
- Nov 14, 2038method-of-use (U-3441)US 11458104
FDA exclusivities (3)
- Jun 28, 2026ODE-267Orphan Drug (7y)
- Jun 28, 2026ODE*ODE*
- Jun 28, 2026ODE*ODE*
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that